Stockreport

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics, Inc.  (BOLT) 
PDF REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapi [Read more]